Suchergebnisse - "SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2"

PubPharm (485)

1

ACE2 Receptor-Targeted Inhaled Nanoemulsions Inhibit SARS-CoV-2 and Attenuate Inflammatory Responses

enthalten in: Advanced materials (Deerfield Beach, Fla.) | 2024

von Wang, H. | Luo, S. | Xie, M. | +11

2

Vaccine-carditis study : Spanish multicenter registry of inflammatory heart disease after COVID-19 vaccination

enthalten in: Clinical research in cardiology : official journal of the German Cardiac Society | 2024

von Pastor Pueyo, P. | Gambó Ruberte, E. | Gayán Ordás, J. | +31

3

Long-term risks of respiratory diseases in patients infected with SARS-CoV-2 : a longitudinal, population-based cohort study

enthalten in: EClinicalMedicine | 2024

von Meng, M. | Wei, R. | Wu, Y. | +10

4

Long-term risks of respiratory diseases in patients infected with SARS-CoV-2: a longitudinal, population-based cohort studyResearch in context

in: EClinicalMedicine | 2024

von Meijun Meng | Rui Wei | Yanjun Wu | +10

5

Clomipramine inhibits dynamin GTPase activity by L-α-phosphatidyl-L-serine stimulation

enthalten in: Journal of biochemistry | 2023

von Miyoshi, H. | Otomo, M. | Takahashi, K.

6

Blood levels of d-amino acids reflect the clinical course of COVID-19

enthalten in: Biochemistry and biophysics reports | 2023

von Kimura-Ohba, S. | Takabatake, Y. | Takahashi, A. | +4

7

Vaccine–carditis study: Spanish multicenter registry of inflammatory heart disease after COVID-19 vaccination

enthalten in: Zeitschrift für Kardiologie | 2023

von Pastor Pueyo, P. | Gambó Ruberte, E. | Gayán Ordás, J. | +31

8

A Global, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Study to Evaluate the Efficacy, Safety, and Immunogenicity of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) in Adults Aged 18 Years and Older : A Global, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Study to Evaluate the Efficacy, Safety, and Immunogenicity of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) in Adults Aged 18 Years and Older

enthalten in: WHO International Clinical Trials Registry Platform | 2023

9

A Partially-Blinded, Randomized, Phase 3 Study to Evaluate the Immunogenicity and Safety of CpG/Alum-adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Subunit Vaccine (SCB-2019) in Healthy Adults and Individuals with HIV Infection : Phase 3 Study of Immunogenicity and Safety of Adjuvanted SARS-CoV-2 (SCB 2019) Vaccine in Healthy Adults and Individuals with HIV Infection

enthalten in: WHO International Clinical Trials Registry Platform | 2023

10

A Phase III Clinical Trial of Influenza Virus Vector Covid-19 Vaccine for Intranasal Spray (DelNS1-2019-nCoV-RBD-OPT1) : A Global, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial to Evaluate the Protective Efficacy and Safety of Influenza Virus Vector Covid-19 Vaccine for Intranasal spray (DelNS1-2019-nCoV-RBD-OPT1) in Adults Aged 18 Years and Older.

enthalten in: WHO International Clinical Trials Registry Platform | 2023

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[49]